AMES, Iowa--(BUSINESS WIRE)--BioForce Nanosciences, Inc., a wholly owned subsidiary of BioForce Nanosciences Holdings, Inc. (OTCBB:BFNH), announced today a new division to the Company. As of July 15, Dr. Saju Nettikadan is director of the “Emerging Technologies” division of BioForce. Dr. Nettikadan will oversee the division dedicated to commercializing in-house research and development efforts, enabling collaborations with external R&D consumers of BioForce’s instruments. Dr. Nettikadan has been an integral employee of BioForce for nearly nine years and has been the project director for the previously publicized ViriChip™ platform and Chip-on-a-Tip™ projects. He holds a doctorate from The Ohio State University.
